There is still a lot of crucial research that must be undertaken, but there has been great progress regarding further understanding the links between metabolic peptides like GLP-1, GIP, and PP, as well as their agonists and properties, in order to combat obesity and neuroinflammation. The gene discussed is GIP; the disease is obesity due to melanocortin 4 receptor deficiency.